The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 610.00
Bid: 612.00
Ask: 628.00
Change: 2.00 (0.33%)
Spread: 16.00 (2.614%)
Open: 610.00
High: 610.00
Low: 610.00
Prev. Close: 608.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

23 Jun 2014 07:00

RNS Number : 1868K
Porvair PLC
23 June 2014
 

For immediate release 23 June 2014

 

Porvair plc

Half yearly results for the six months ended 31 May 2014

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, today announces its half yearly results for the six months ended 31 May 2014.

 

Highlights

· Encouraging financial performance:

o Revenues grew by 32% (36% in constant currency) to £51.0m (2013: £38.6m).

o Profit before tax increased by 27% to £3.8m (2013: £3.0m (restated*)).

o Earnings per share up 25% to 6.0 pence (2013: 4.8 pence (restated)).

o Net debt of £1m (30 November 2013: net cash of £0.6m).

· Microfiltration:

o Revenues increased 48%.

o Large contracts running smoothly and contributing significantly to revenue growth.

o Expansion in UK and USA underway.

o Order position healthy.

· Metals Filtration:

o Revenues up 5% (12% at constant currency).

o Market share gains from patented products continue to drive growth.

o Promising new product development.

· Interim dividend increased to 1.2 pence (2013: 1.1 pence).

 

* restatement for the implementation of IAS19 Revised, 2013 profit before tax as previously reported was £3.1m

 

Commenting on the outlook, Ben Stocks, Chief Executive, said:

"Porvair's strategic direction and operating objectives are unchanged and continue to deliver good results. We focus on niche markets which have structural growth drivers. 2014 has started strongly, and order books are healthy across the Group. The revenue benefits of previously announced large contracts are showing through with underlying growth also healthy. We continue to invest in US and UK capacity expansion and new product development. There is considerable opportunity in the Porvair businesses. The Board's outlook remains positive."

 

 

For further information please contact:

Porvair plc

0207 466 5000

today

Ben Stocks, Chief Executive

01553 765 500

thereafter

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Clare Akhurst

 

A copy of the presentation that accompanies these results is available at www.porvair.com 

Operating Review

 

Porvair continued to make progress against its objectives during the year as is shown in the results for the six months ended 31 May 2014. Revenues grew 32% (36% at constant currency) to £51.0m (2013: £38.6m); profit before tax grew 27% to £3.8m (2013: £3.0m (restated)); and earnings per share increased by 25% to 6.0 pence (2013: 4.8 pence (restated)). As explained below revenues in 2014 are boosted by the impact of three large projects. Underlying revenues, excluding these projects, grew by 8% (12% at constant currency).

 

The second half of 2014 has started well. Order books are healthy. The fundamentals of the principal markets in which the Group operates - aviation, energy, water, and aluminium - are satisfactory.

 

Encouraging progress towards key operating objectives was made in the period, including:

 

Microfiltration:

· Previously announced large contracts are running smoothly.

· Capacity expansion in the UK and USA is underway.

· Aerospace filtration continues to grow - record revenues were recorded in the period.

· Seal Analytical posted record results.

Metals filtration:

· Continuing market share gains from patented products drove growth despite currency headwinds.

· New product development projects are going well and early commercial sales have started.

 

Strategic statement

Porvair's strategy has remained consistent for several years. It is to generate shareholder value through the development of specialist filtration and environmental technology businesses, both organically and by acquisition. Such businesses have certain key characteristics in common:

· specialist design or engineering skills are required;

· product use and replacement is mandated by regulation, quality accreditation or a maintenance cycle;

· products will be designed into a customer's systems or products and will typically have long life cycles.

In the five years since 2009 this strategy has delivered revenue growth of 70% (11% CAGR) and cash from operations of £44m. In 2013 the Group's after tax operating profit return on operating capital was 39%.

Business model outline

Porvair's business model is as follows:

1. Focus on end-markets which show long term growth potential and where product use is mandatory.

2. Make new product development a core business activity.

3. Establish geographic presence where end-markets require.

4. Maintain a conservative balance sheet. Re-invest in both organic and acquired growth and pay a progressive dividend.

This business model determines the Group's day-to-day activities:

· We focus on four end-markets: aviation; energy and industrial; environmental laboratories and molten metals. All have clear structural growth drivers.

· Our products are specialist in nature: they typically protect more costly or complex downstream systems. As a result they are replaced regularly. Over 80% of our annual revenues are from repeat orders.

· We encourage new product development in order to generate growth rates in excess of the underlying market. We aim to build good intellectual property around our product developments. Approximately 30% of our revenues are derived from patent protected products.

· Our geographic presence follows the markets we serve. Annualised, 41% of revenues are from customers in the Americas, where aviation and metals filtration are strong. 27% of revenues are from customers in Asia, where sales into water analysis markets are growing and two of our major gasification projects are delivered.

· Porvair is a cash generative business. We aim to maintain a conservative balance sheet, meeting dividend and investment needs within our existing debt facilities. In the last two years we have expanded manufacturing capacity in the UK and China and made five small acquisitions.

Operating structure

· The Group has two divisions. The Microfiltration division serves the aviation, environmental laboratory and energy/industrial markets. The Metals Filtration division serves global aluminium, NAFTA iron foundry and super-alloy markets.

· The Group manufactures in the UK, US, Germany and China.

 

Plans for investment and future development

In the January 2014 preliminary announcement we set out our plans to increase capital investment in the Group in 2014. These projects are:

· The consolidation and expansion of our operations at New Milton (UK), into a facility acquired in February 2014, and the addition of machining capacity in Fareham to enable aviation and industrial filtration growth. Aviation sales have grown strongly recently and we need more capacity.

· The expansion of facilities in Caribou, Maine, US following the acquisition of Eisenmann Metallurgical in 2013.

· Further investments in manufacturing capabilities in Metals filtration in both the USA and China

· Expansion of facilities for Seal Analytical in the US, UK and Germany to allow for further growth following the 2013 acquisition of Thomas Cain.

As we stated in January 2014, these and other projects will increase expected capital investment in 2014 to levels roughly three times higher than the average of recent years. This will be met by in-year cash flows. Capacity increases and equipment upgrades are necessary due to the impact that new product introductions and small acquisitions have had on the business. We expect this capacity pressure to continue, with the 2014 product development pipeline looking promising in bioscience filtration; Metals Filtration manufacturing; water analysis; and nuclear filtration. Encouraging these projects is central to Porvair's business model.

These interim results show the benefits of the earlier large contract wins. These are principally those with POSCO of South Korea, the UK Government and Reliance Industries of India. The financial impact of these larger contracts, which are accounted for under long term contract accounting rules, are expected to cause the published results over the next three years to fluctuate more than has generally been the case.

· These results demonstrate the expected one-off boost to revenues in 2014 from these contracts. Revenues in 2014, as a result, are expected to be much higher than the underlying growth rate would normally deliver. Thereafter the impact on revenue of the large contracts will diminish and revenues are then expected to return to underlying levels.

· We recognise profits only once we are satisfied that we have provided for the outstanding liabilities and mitigated potential risks and warranties on each project. Profit recognition could therefore be spread over the period between 2013 and 2017.

· Cash inflows are expected to arise principally between 2013 and 2015. Whilst we will maintain suitable cash reserves against the possible needs of the contracts, this cash will be used to re-invest in the business as outlined above.

 

Divisional review

 

Microfiltration

2014

2013

Growth

£m

£m

%

Revenue

36.3

24.5

48

Operating profit

4.0

3.5

15

 

This division includes the three large projects described above, which are the major contributor to the high revenue growth. Underlying performance has been sound with underlying revenue growth, excluding the three large contracts, of 10% in the period.

 

All three large projects are proceeding according to plan:

· Under the $10m POSCO contract announced in 2011, all manufactured parts have been shipped to South Korea and the division has started to build the char filtration package. Training materials have been developed for its operation. The plant is expected to begin commissioning in early 2015.

· A much larger contract for a similar project was signed in February 2013 with Reliance Industries for their installation at Jamnagar, India. First deliveries have been made with more scheduled for the second half.

· An £11.3m contract with the UK Government was announced in January 2013, for which manufacturing has begun.

 

All three projects will impact the financial results of the Group over several years, with significant revenue recognised throughout 2014.

 

In addition to these contracts, orders in the energy sector have again been robust. Aerospace revenues were at record levels in the period. In the US the integration of Chand Eisenmann into our operations is going as planned and like for like revenue growth was 15%. Order books for the second half are healthy.

 

Capital investment in this division has increased. More machining capacity is starting to feed through into capacity increases, a new facility in New Milton has been acquired and will be completed towards the end of 2014 and expansion of the plant in Caribou, Maine, US will be completed in early 2015.

 

Seal Analytical had a strong start to the year. Revenues grew 29% in the first half, driven by strong underlying demand in China and the US and helped by the 2013 acquisition of Thomas Cain. Business growth and the need for expanded technical facilities mean that we will invest in capacity expansion in the UK, USA and Germany during the second half.

 

Metals Filtration

2014

2013

Growth

£m

£m

%

Revenue

14.8

14.1

5

Operating profit

1.2

1.1

8

 

Revenues grew 5% (12% in constant currency) to £14.8m, with the stronger operating margins noted in previous announcements contributing to better profitability which increased 8% (15% in constant currency) to £1.2m.

 

We continue to make steady market share gains from growing customer adoption of our patented range of filters: Selee CSX™ for aluminium; Selee SA™ for NiCo alloys; and Selee IC™ for grey and ductile iron. All three are widely accepted due to their better environmental impact and filtration efficiency. Sales of Selee IC™, used primarily in the foundry industry are at record levels.

 

Incremental product improvements are being made to the Selee CSX™ and Selee IC™ products to broaden their market appeal and offer range extensions. One of these is a promising new filter for lithium aluminium, a material increasingly being used in aerospace applications. Filter trials are going well. Revenues from other new filter projects, notably carbon foam filters and structured products are starting to grow steadily, albeit from a modest base.

 

Metals Filtration's revenue in China has been satisfactory and is expected to grow in the second half. The new plant, opened at the end of last year, is running well and we will consider further expansion later in the year.

 

Earnings per share and dividends

The basic earnings per share for the period increased 25% to 6.0 pence (2013: 4.8 pence (restated)). The Board is declaring an increased interim dividend of 1.2 pence (2013: 1.1 pence) per share.

 

Cash flow and net debt

Cash generated from operations in the six months to 31 May 2014 was £2.7m (2013: £2.0m). Working capital increased in the period by £3.0m (2013: £2.7m) principally as a result of timings of payments and receipts in relation to the three large projects.

 

Net interest paid was £0.2m (2013: £0.2m). Tax payments increased to £1.2m (2013: £0.8m).

 

Capital expenditure increased to £2.9m (2013: £0.5m), reflecting the significant capacity expansion being undertaken by the Group in the year.

 

Closing net debt at 31 May 2014 was £1.0m (30 November 2013: net cash of £0.6m).

 

Current trading and outlook

Porvair's strategic direction and operating objectives are unchanged and continue to deliver good results. We focus on niche markets which have structural growth drivers. 2014 has started strongly, and order books are healthy across the Group. The revenue benefits of previously announced large contracts are showing through with underlying growth also healthy. We continue to invest in US and UK capacity expansion and new product development. There is considerable opportunity in the Porvair businesses. The Board's outlook remains positive.

  Ben Stocks

Group Chief Executive

 

 

Related parties

There were no related party transactions in the six months ended 31 May 2014 (2013: none).

 

Principal risks

Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. The principal risks and uncertainties for the remaining six months of the financial year are discussed below. Further details of the Group's risk profile analysis can be found in the Strategic Report section of the Annual Report for the year ended 30 November 2013.

 

Certain elements of the Group's order position, although healthy at 31 May 2014, can change quickly in the face of changing economic circumstances. The Metals Filtration division and environmental laboratory supplies and general industrial filtration within the Microfiltration division all have relatively short lead times and order cycles and, therefore, revenues are subject to fluctuations, which could have a material effect on the Group's results for the balance of 2014.

 

The Microfiltration division serves several customers whose orders are large relative to Porvair's overall order book. Should any of these be cancelled or delayed it may affect the Group's results for the balance of 2014.

 

Forward looking statements

Certain statements in this half yearly financial information are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

 

 

 

 

 

Consolidated income statement

For the six months ended 31 May

Six months ended 31 May

2014

2013

Note

Unaudited

Unaudited

Restated

£'000

£'000

Revenue

1

51,024

38,604

Cost of sales

(36,130)

(25,406)

Gross profit

14,894

13,198

Other operating expenses

(10,699)

(9,803)

Operating profit

1

4,195

3,395

Interest payable and similar charges

(413)

(410)

Profit before income tax

3,782

2,985

Income tax expense

(1,149)

(951)

Profit for the period attributable to shareholders

2,633

2,034

Earnings per share (basic)

2

6.0p

4.8p

Earnings per share (diluted)

2

5.9p

4.7p

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 31 May

Six months ended 31 May

2014

Unaudited

2013

Unaudited

Restated

£'000

£'000

Profit for the period

2,633

2,034

Other comprehensive income:

Items that will not be reclassified to profit or loss

Actuarial losses in defined benefit pension plans net of tax

-

65

Items that may be subsequently reclassified to profit or loss

Exchange differences on translation of foreign subsidiaries

(794)

323

Changes in fair value of interest rate swaps held as a cash flow hedge

20

34

Changes in the fair value of foreign exchange contracts held as a cash flow hedge

11

-

(763)

357

Net other comprehensive income

(763)

422

Total comprehensive income for the period attributable to shareholders of Porvair plc

 

1,870

 

2,456

 

The accompanying notes are an integral part of this interim financial information. The basis of the restatement of 2013 is described in note 12.

 

 

Consolidated balance sheet

As at 31 May

 

As at 31 May

As at 30 November

Note

2014

Unaudited

2013

Unaudited

2013

Audited

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

4

10,865

8,185

9,006

Goodwill and other intangible assets

4

41,766

39,986

42,535

Deferred tax asset

2,468

2,385

2,440

Derivative financial instruments

-

-

144

55,099

50,556

54,125

Current assets

Inventories

12,733

11,211

11,617

Trade and other receivables

18,570

12,817

13,978

Derivative financial instruments

985

-

1,027

Cash and cash equivalents

5

6,428

7,666

6,773

38,716

31,694

33,395

Current liabilities

Trade and other payables

(24,230)

(13,893)

(19,472)

Current tax liabilities

(1,103)

(1,196)

(995)

Bank overdraft and loans

(984)

(988)

(983)

Derivative financial instruments

-

(268)

(20)

(26,317)

(16,345)

(21,470)

Net current assets

12,399

15,349

11,925

Non-current liabilities

Bank loans

(6,440)

(9,708)

(5,211)

Retirement benefit obligations

(11,787)

(8,425)

(11,875)

Other payables

(298)

-

(1,159)

Provisions for other liabilities and charges

(132)

(122)

(125)

(18,657)

(18,255)

(18,370)

Net assets

48,841

47,650

47,680

Capital and reserves

Share capital

6

883

867

875

Share premium account

6

35,155

34,732

35,147

Cumulative translation reserve

7

(1,103)

935

(309)

Retained earnings

7

13,906

11,116

11,967

Total equity

48,841

47,650

47,680

 

The interim financial information on pages 7 to 17 was approved by the Board of Directors on 20 June 2014 and was signed on its behalf by:

 

Ben Stocks Chris Tyler

Group Chief Executive Group Finance Director

 

The accompanying notes are an integral part of this interim financial information.

Consolidated cash flow statement

For the six months ended 31 May

Six months ended 31 May

Note

2014 Unaudited

2013 Unaudited

£'000

£'000

Cash flows from operating activities

Cash generated from operations

8

2,658

1,966

Interest paid

(207)

(185)

Tax paid

(1,195)

(838)

Net cash generated from operating activities

1,256

943

Cash flows from investing activities

Acquisition of subsidiaries (net of cash acquired)

-

(63)

Purchase of property, plant and equipment

4

(2,866)

(374)

Purchase of intangible assets

4

(12)

(153)

Proceeds from sale of property, plant and equipment

9

478

Net cash used in investing activities

(2,869)

(112)

Cash flows from financing activities

Net proceeds from the issue of ordinary shares

6

16

236

Increase in/(repayment of) borrowings

9

1,333

(886)

Net cash generated from/(used in) financing activities

1,349

(650)

Net (decrease)/increase in cash and cash equivalents

9

(264)

181

Effects of exchange rate changes

(81)

210

(345)

391

Cash and cash equivalents at the beginning of the period

6,773

7,275

Cash and cash equivalents at the end of the period

5

6,428

7,666

 

 

The accompanying notes are an integral part of this interim financial information.

Consolidated statement of changes in equity

For the six months ended 31 May (Unaudited)

 

 

Share capital

£'000

Share premium account

£'000

Cumulative translation

reserve

£'000

Retained earnings

Restated

£'000

 

Total

Restated

£'000

Balance at 1 December 2012

852

34,511

612

9,199

45,174

Profit for the period

-

-

-

2,034

2,034

Other comprehensive income for the period:

Exchange differences on translation of foreign subsidiaries

-

-

323

-

323

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

34

 

34

Actuarial losses in defined benefit pension plans net of tax

 

-

 

-

 

-

 

65

 

65

Total comprehensive income for the period

-

-

323

2,133

2,456

Transactions with owners:

Proceeds from shares issued, net of costs

15

221

-

-

236

Employee share option schemes:

Value of employee services net of tax

-

-

-

478

478

Dividends approved as final or paid

-

-

-

(694)

(694)

Balance at 31 May 2013

867

34,732

935

11,116

47,650

Balance at 1 December 2013

875

35,147

(309)

11,967

47,680

Profit for the period

-

-

-

2,633

2,633

Other comprehensive income for the period:

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

(794)

 

-

 

(794)

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

20

 

20

Changes in the fair value of foreign exchange contracts held as a cash flow hedge

 

-

 

-

 

-

 

11

 

11

Total comprehensive income for the period

-

-

(794)

2,664

1,870

Transactions with owners:

Proceeds from shares issued, net of costs

8

8

-

-

16

Employee share option schemes:

Value of employee services net of tax

-

-

-

70

70

Dividends approved as final or paid

-

-

-

(795)

(795)

Balance at 31 May 2014

883

35,155

(1,103)

13,906

48,841

 

The accompanying notes are an integral part of this interim financial information.

 

Notes to the financial information

 

1. Segmental analyses

 

The chief operating decision maker has been identified as the Board of Directors. The Board of Directors review the Group's internal reporting in order to assess performance and allocate resources. Management have determined the operating segments based on this reporting.

 

As at 31 May 2014, the Group is organised on a worldwide basis into two operating segments:

1) Metals Filtration

2) Microfiltration

 

The segment results for the period ended 31 May 2014 are as follows:

 

Six months ended 31 May 2014 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

14,755

36,269

-

51,024

Operating profit/(loss)

1,166

3,963

(934)

4,195

Interest payable and similar charges

-

-

(413)

(413)

Profit/(loss) before income tax

1,166

3,963

(1,347)

3,782

Income tax expense

-

-

(1,149)

(1,149)

Profit/(loss) for the period

1,166

3,963

(2,496)

2,633

 

The segment results for the period ended 31 May 2013 are as follows:

 

Six months ended 31 May 2013 -Unaudited - restated

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

14,081

24,523

-

38,604

Operating profit/(loss)

1,075

3,461

(1,141)

3,395

Interest payable and similar charges

-

-

(410)

(410)

Profit/(loss) before income tax

1,075

3,461

(1,551)

2,985

Income tax expense

-

-

(951)

(951)

Profit/(loss) for the period

1,075

3,461

(2,502)

2,034

 

Other Group operations are included in "Other unallocated". These mainly comprise Group corporate costs, including new business development costs, some research and development costs, general financial costs, and income tax expense.

Segment assets and liabilities

 

At 31 May 2014 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

24,920

57,987

4,480

87,387

Cash and cash equivalents

-

-

6,428

6,428

Total assets

24,920

57,987

10,908

93,815

Segmental liabilities

(3,832)

(18,561)

(3,370)

(25,763)

Retirement benefit obligations

-

-

(11,787)

(11,787)

Borrowings

-

-

(7,424)

(7,424)

Total liabilities

(3,832)

(18,561)

(22,581)

(44,974)

 

At 31 May 2013 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

24,896

45,914

3,774

74,584

Cash and cash equivalents

-

-

7,666

7,666

Total assets

24,896

45,914

11,440

82,250

Segmental liabilities

(2,794)

(9,784)

(2,901)

(15,479)

Retirement benefit obligations

-

-

(8,425)

(8,425)

Borrowings

-

-

(10,696)

(10,696)

Total liabilities

(2,794)

(9,784)

(22,022)

(34,600)

 

At 30 November 2013 - Audited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

24,623

51,606

4,518

80,747

Cash and cash equivalents

-

-

6,773

6,773

Total assets

24,623

51,606

11,291

87,520

Segmental liabilities

(3,360)

(15,459)

(2,952)

(21,771)

Retirement benefit obligations

-

-

(11,875)

(11,875)

Borrowings

-

-

(6,194)

(6,194)

Total liabilities

(3,360)

(15,459)

(21,021)

(39,840)

 

 

Geographical analysis

Revenue

Six months ended 31 May

2014

Unaudited

2013

Unaudited

By destination

£'000

By origin

£'000

By destination

£'000

By origin

£'000

United Kingdom

8,515

25,639

7,901

15,759

Continental Europe

6,339

4,014

5,838

3,035

United States of America

15,845

20,631

16,467

18,962

Other NAFTA

3,232

-

1,626

-

South America

834

-

697

-

Asia

15,147

740

4,733

848

Australasia

432

-

622

-

Africa

680

-

720

-

51,024

51,024

38,604

38,604

 

 

2. Earnings per share

Six months ended 31 May

 

2014

Unaudited

2013

Unaudited

 

 

Earnings

 

 

 

£'000

Weighted average number of shares

Per share amount

 

 

Pence

Earnings

Restated

 

 

£'000

Weighted average number of shares

Per share amount

Restated

 

Pence

Basic EPS - Earnings attributable to ordinary shareholders

 

 

2,633

 

 

44,017,345

 

 

6.0

 

 

2,034

 

 

42,813,469

 

 

4.8

Effect of dilutive securities - share options

 

-

 

283,053

 

(0.1)

 

-

 

363,563

 

(0.1)

Diluted EPS

2,633

44,300,398

5.9

2,034

43,177,032

4.7

 

 

3. Dividends per share

Six months ended 31 May

2014

2013

Unaudited

Unaudited

Per share

£'000

Per share

£'000

Final dividend approved

1.80p

795

1.60p

694

 

The final dividend approved was paid to shareholders on 6 June 2014.

 

The Directors have declared an interim dividend of 1.2 pence (2013: 1.1 pence) per share to be paid on 5 September 2014 to shareholders on the register at the close of business on 1 August 2014. The ex-dividend date for the shares is 30 July 2014.

 

4. Property, plant and equipment and goodwill and other intangible assets

 

Six months ended 31 May 2014 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2013

9,006

42,535

51,541

Additions

2,866

12

2,878

Disposals

(18)

-

(18)

Depreciation and amortisation

(849)

(177)

(1,026)

Exchange movements

(140)

(604)

(744)

Closing net book amount at 31 May 2014

10,865

41,766

52,631

 

 

Six months ended 31 May 2013 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2012

8,641

39,983

48,624

Additions

374

153

527

Disposals

(360)

-

(360)

Depreciation and amortisation

(735)

(181)

(916)

Exchange movements

265

31

296

Closing net book amount at 31 May 2013

8,185

39,986

48,171

 

5. Cash and cash equivalents

 

As at 31 May

As at 30 November

2014

Unaudited

£'000

2013

Unaudited

£'000

2013

Audited

£'000

Cash at bank and in hand

6,428

7,666

6,773

Cash and cash equivalents

6,428

7,666

6,773

 

 

6. Share capital and premium

Number of shares (thousands)

Ordinary shares

Unaudited

Share premium account

Unaudited

 

Total

Unaudited

£'000

£'000

£'000

At 1 December 2012

42,613

852

34,511

35,363

Employee share options schemes:

Exercise of options under share option schemes

 

748

 

15

 

221

 

236

At 31 May 2013

43,361

867

34,732

35,599

At 1 December 2013

43,734

875

35,147

36,022

Employee share options schemes:

Exercise of options under share option schemes

 

433

 

8

 

8

 

16

At 31 May 2014

44,167

883

35,155

36,038

 

The authorised number of ordinary shares is 75 million (2013: 75 million) shares with a par value of 2.0 pence (2013: 2.0 pence) per share. All issued shares are fully paid. 433,345 (2013:748,500) ordinary shares of 2p each were issued in the period on the exercise of employee share options for a cash consideration of £16,000 (2013: £236,000).

 

7. Other reserves

Cumulative translation reserve

 

Unaudited

 

Retained earnings

Restated

Unaudited

£'000

£'000

At 1 December 2012

612

9,199

Profit for the period attributable to shareholders

-

2,034

Direct to equity:

Final dividends approved

-

(694)

Share based payments

-

208

Tax on share based payments

-

270

Interest rate swap cash flow hedge

-

34

Actuarial losses in defined benefit pension plans net of tax

 

-

 

65

Exchange differences

323

-

At 31 May 2013

935

11,116

At 1 December 2013

(309)

11,967

Profit for the period attributable to shareholders

-

2,633

Direct to equity:

Final dividends approved

-

(795)

Share based payments

-

238

Tax on share based payments

-

(168)

Interest rate swap cash flow hedge

-

20

Foreign exchange contract cash flow hedge

-

11

Exchange differences

(794)

-

At 31 May 2014

(1,103)

13,906

 

8. Cash generated from operations

Six months ended 31 May

2014

 

Unaudited

£'000

2013

Restated

Unaudited

£'000

Operating profit

4,195

3,395

Non-cash pension charge

260

215

Share based payments

238

208

Depreciation and amortisation

1,026

916

Loss/(profit) on disposal of property, plant and equipment

9

(118)

Operating cash flows before movement in working capital

5,728

4,616

Increase in inventories

(1,273)

(673)

Increase in trade and other receivables

(4,558)

(494)

Increase/(decrease) in payables

2,761

(1,483)

Increase in working capital

(3,070)

(2,650)

Cash generated from operations

2,658

1,966

 

9. Reconciliation of net cash flow to movement in net debt

Six months ended 31 May

2014

Unaudited

£'000

2013

Unaudited

£'000

Net (decrease)/increase in cash and cash equivalents

(264)

181

Effects of exchange rate changes

22

(227)

(Increase in)/repayment of borrowings

(1,333)

886

Net cash/(debt) at the beginning of the period

579

(3,870)

Net debt at the end of the period

(996)

(3,030)

 

10. Exchange rates

Exchange rates for the US dollar during the period were:

Average rate to 31 May 14

Average rate to 31 May 13

Closing rate at 31 May 14

Closing rate at 30 Nov 13

Unaudited

Unaudited

Unaudited

Unaudited

US dollar

1.66

1.55

1.68

1.64

 

11. Seasonality

The results for the six months ended 31 May 2014 are impacted by a lower number of working days in the first six months of the year than in the second half of the year.

 

12. Basis of preparation

Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.

 

This unaudited condensed half-yearly consolidated financial information for the six months ended 31 May 2014 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Conduct Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. The condensed half-yearly consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2013, which were approved by the Board of Directors on 24 January 2014 and which have been prepared in accordance with IFRSs as adopted by the European Union.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 November 2013, as described in those financial statements, except as described below:

 

IAS 19 (revised) 'Employee benefits' amends the accounting for employment benefits. The Group has applied the standard retrospectively in accordance with the transition provisions of the standard. The impact on the Group has been in the following areas:

 

· The standard replaces the interest cost on the defined benefit obligation and the expected return on plan assets with a net interest cost based on the net defined benefit asset or liability and the discount rate, measured at the beginning of the year. There is no change to determining the discount rate. This has increased the income statement charge as the discount rate applied to assets is lower than the expected return on assets. This has no effect on total comprehensive income as the increased charge in profit or loss is offset by a credit in other comprehensive income. The effect has been that the income statement charge for the period ended 31 May 2013 has increased by £65,000 as the discount rate was lower than the expected return on assets. The effect of the change in accounting policy on deferred tax was immaterial.

 

Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.

 

This condensed half-yearly consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the revaluation of certain current assets, financial assets and financial liabilities held for trading and derivative contracts, which are held at fair value.

 

The preparation of condensed half-yearly consolidated financial information in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed half-yearly consolidated financial information and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates.

 

 

After having made appropriate enquiries, including a review of progress against the Group's budget for 2014, its medium term plans and taking into account the banking facilities available until January 2018, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing this condensed half-yearly consolidated financial information.

 

This condensed half-yearly consolidated financial information and the comparative figures does not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2013, which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

The condensed half-yearly financial statements do not include all financial risk management information and disclosures required in the annual financial statements; they should be read in conjunction with the Group's annual financial statements for the year ended 30 November 2013. There have been no changes in the risk management department or in any risk management policies since the year end.

 

This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website www.porvair.com.

 

 

Statement of directors' responsibilities

 

The Directors confirm that this condensed half-yearly consolidated financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

§ an indication of important events that have occurred during the first six months of the year, their impact on the condensed half-yearly consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

§ material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.

 

The Directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2013. Dr Krishnamurthy Rajagopal was appointed to the Board as a non-Executive Director on 1 April 2014 and Andrew Walker resigned from the Board at the Annual General Meeting on 8 April 2014. A list of current Directors is maintained on the Porvair plc website www.porvair.com.

 

By order of the board

 

 

 

 

Ben Stocks

Group Chief Executive

 

 

 

 

Chris Tyler

Group Finance Director

 

20 June 2014

 

 

Independent review report to Porvair plc

Report on the interim financial information

Our conclusion

We have reviewed the interim financial information defined below, in the half-yearly results of Porvair plc for the six months ended 31 May 2014. Based on our review, nothing has come to our attention that causes us to believe that the interim financial information is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

This conclusion is to be read in the context of what we say in the remainder of this report.

What we have reviewed

The interim financial information which is prepared by Porvair plc comprise:

· the condensed consolidated balance sheet as at 31 May 2014;

· the condensed consolidated income statement and statement of comprehensive income for the period then ended;

· the condensed consolidated statement of cash flows for the period then ended;

· the condensed consolidated statement of changes in equity for the period then ended; and

· the explanatory notes to the condensed consolidated interim financial statements.

As disclosed in note 12, the financial reporting framework that has been applied in the preparation of the full annual financial statements of the group is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union.

The condensed consolidated interim financial statements included in the half-yearly results have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

What a review of condensed consolidated financial statements involves

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We have read the other information contained in the half-yearly results and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed consolidated interim financial statements.

Responsibilities for the condensed consolidated interim financial statements and the review

Our responsibilities and those of the directors

The half-yearly results including the condensed consolidated interim financial statements, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly results in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

Our responsibility is to express to the company a conclusion on the condensed consolidated interim financial statements in the half-yearly results based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure and Transparency Rules of the Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

PricewaterhouseCoopers LLP

Chartered Accountants

20 June 2014

Cambridge

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BXGDLLXDBGSG
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.